Zumair Hayath: Writing original draft
Pups from rd10 litters were randomly assigned to respective treatment groups
mazdutide and survodutide for GLP-1/glucagon), triple agonists (retatrutide), an amylin analog (cagrilintide), and pre-mixed blends (cagri-sema, retatrutide+cagrilintide)
For example, if the company offered an HRA with a value of $3,000 and anticipated that 5% of covered adults would fill prescriptions, it could adjust the value of the HRA to, say, $2,000 the following year if utilization jumped to 8% of covered adults
## Retatrutide Cost and Availability in 2026: Current Pricing Landscape Retatrutide, the triple agonist (GIP/GLP-1/glucagon) that produced up to 24.2% weight loss in Phase 2 trials, remains in Phase 3 clinical development as of July 2026